Home > Stocks & Markets > HealthcareAgenus IncMost RecentCompany & Industry OverviewsAgenus: Attractive Entry Level after Recent PullbackThis year, Agenus (AGEN) stock has fluctuated widely. The clinical-stage biotechnology company’s stock fell from $3.88 in February to about $2.12 in August.
Company & Industry OverviewsAgenus: Attractive Entry Level after Recent PullbackThis year, Agenus (AGEN) stock has fluctuated widely. The clinical-stage biotechnology company’s stock fell from $3.88 in February to about $2.12 in August.
